Phase 1 Thyroid Cancer Trial, Recruiting (NCT04589624)

Phase 1 Thyroid Cancer Trial, Recruiting NCT04589624 Sponsor: M.D. Anderson Cancer Center Condition: Thyroid Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT04589624 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Thyroid Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are willing and able to give your consent to take part in the study
You have been told that this study is investigational (still being researched)
You have been diagnosed with thyroid cancer or another type of cancer in the head or neck area, and are planning to receive treatment for it

Who may not be able to join:

You have a history of severe claustrophobia (strong fear of enclosed spaces)
You have an implanted medical device (such as a pacemaker) that is controlled by electricity, magnets, or mechanics, which could make having an MRI scan unsafe
You have a history of irregular heartbeat (confirm with trial site)
You are allergic to a contrast dye called Gadavist, which is given through a vein during certain scans
Your kidneys are not working well enough, based on a blood test result measuring kidney function (confirm with trial site)
You are female and are currently pregnant or breastfeeding at the time of giving consent

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Stephen Y Lai, M.D. Anderson Cancer Center

Phone: 713-792-6528

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04589624

Sponsor: M.D. Anderson Cancer Center

Phase: Phase 1

Status: Recruiting

Condition: Thyroid Cancer

Trial contact: 713-792-6528

More information: https://clinicaltrials.gov/study/NCT04589624

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are willing and able to give your consent to take part in the study
You have been told that this study is investigational (still being researched)
You have been diagnosed with thyroid cancer or another type of cancer in the head or neck area, and are planning to receive treatment for it

Who may not be able to join:

You have a history of severe claustrophobia (strong fear of enclosed spaces)
You have an implanted medical device (such as a pacemaker) that is controlled by electricity, magnets, or mechanics, which could make having an MRI scan unsafe
You have a history of irregular heartbeat (confirm with trial site)
You are allergic to a contrast dye called Gadavist, which is given through a vein during certain scans
Your kidneys are not working well enough, based on a blood test result measuring kidney function (confirm with trial site)
You are female and are currently pregnant or breastfeeding at the time of giving consent

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 1

Sponsor

M.D. Anderson Cancer Center

Registry

ClinicalTrials.gov

Start date

12 August 2020

Est. completion

31 May 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Metabolic imaging data from hyperpolarized magnetic resonance imaging (hpMRI) methods

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov